Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Unraveling Enterococcus susceptibility to quaternary ammonium compounds, genes, phenotypes, and the impact of environmental conditions

  • Fernandes Pereira, Ana Paula|||0000-0003-3470-253X
  • Antunes, Patrícia|||0000-0002-3553-2678
  • Bierge, Paula|||0000-0003-0917-3445
  • Willems, Rob J. L.
  • Corander, Jukka
  • Coque, Teresa M.
  • Pich, Oscar Q.|||0000-0003-3561-630X
  • Peixe, Luisa
  • Freitas, Ana R.|||0000-0002-7326-4133
  • Novais, Carla|||0000-0002-3826-6731
Quaternary ammonium compounds (QACs) have been extensively used in the community, healthcare facilities, and food chain, in concentrations between 20 and 30,000 mg/L. Enterococcus faecalis and Enterococcus faecium are ubiquitous in these settings and are recognized as nosocomial pathogens worldwide, but QACs' activity against strains from diverse epidemiological and genomic backgrounds remained largely unexplored. We evaluated the role of Enterococcus isolates from different sources, years, and clonal lineages as hosts of QACs tolerance genes and their susceptibility to QACs in optimal, single-stress and cross-stress growth conditions. Only 1% of the Enterococcus isolates included in this study and 0.5% of publicly available Enterococcus genomes carried qacA/B, qacC, qacG, qacJ, qacZ, qrg, bcrABC or oqxAB genes, shared with.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Is ampicillin plus cephalosporins a therapeutic option for Ampicillin-Susceptible Enterococcus faecium?

  • Bierge, Paula|||0000-0003-0917-3445
  • Gómez-Sánchez, Inmaculada|||0000-0002-4255-0882
  • García de la Mària, Cristina|||0000-0002-0585-9469
  • Sánchez-Osuna, Miquel|||0000-0001-5267-4814
  • Capilla, Silvia|||0000-0002-7274-2973
  • Casabella Pernas, Antonio|||0000-0002-2534-3689
  • Espasa, Mateu|||0000-0003-4822-1024
  • Novais, Carla|||0000-0002-3826-6731
  • Miró, José M.|||0000-0001-8057-7755
  • Pich, Oscar Q.|||0000-0003-3561-630X
  • Gasch, Oriol|||0000-0001-8518-458X
Objectives: Enterococcus faecium, a significant hospital associated pathogen, poses substantial treatment challenges. While combinations of ampicillin with cephalosporins are first-line therapies to treat Enterococcus faecalis high-mortality-rates infections, their efficacy against ampicillin-susceptible E. faecium (ASEfm) is less clear. This study evaluates the effectiveness of combining ampicillin with ceftriaxone or ceftaroline against ASEfm strains. Methods: Ten ASEfm bloodstream isolates from complicated infections were analyzed. Susceptibility to several antibiotics, including ceftriaxone, ceftaroline, and cefotaxime, was determined using standard methods. Time-kill assays were conducted to assess the synergistic and additive effects of ampicillin in combination with ceftriaxone or ceftaroline. Results: Time-kill studies revealed that ampicillin combined with ceftaroline demonstrated synergistic and/or additive effects in 7 out of 10 strains analyzed. In contrast, ampicillin combined with ceftriaxone showed less pronounced synergy, with only 3 out of 10 strains exhibiting synergistic and/or additive effects. Conclusions: Our findings indicate that ampicillin combined with ceftaroline, or ceftriaxone provides synergistic activity against some but not all ASEfm clinical isolates. The observed synergy suggests that these combinations could offer a potential therapeutic option for challenging ASEfm infections.